Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymorePaul G Ambrose, Sujata M Bhavnani, Christopher M Rubino, et al.
Arthritis and Rheumatism|September 1, 1994
The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndromeS J Bowman, M Sivakumaran, N Snowden, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2025
Population pharmacokinetic analysis of tobramycin in serum and ELF using data from patients with pneumoniaScott A Van Wart, Michael Trang, M Courtney Safir, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2009
Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremiaChristopher M Rubino, Scott A Van Wart, Sujata M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremiaSujata M Bhavnani, Julie A Passarell, Joel S Owen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2013
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and AztreonamMichael N Dudley, Paul G Ambrose, Sujata M Bhavnani, et al.
The Pediatric Infectious Disease Journal|July 23, 2008
Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonateJohn S Bradley, Jason B Sauberan, Paul G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection ModelB D VanScoy, S Jones, H Conde, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation SolutionElizabeth A Lakota, Nobuo Sato, Tomokazu Koresawa, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumoniaChristopher M Rubino, Alan Forrest, Sujata M Bhavnani, et al.
Pageof 16